Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
3/10/2026
Junshi Secures NMPA Acceptance for Subcutaneous Toripalimab Across 12 ...
3/9/2026
Biocytogen Achieves Key Clinical Milestone as IDEAYA Initiates Phase I...
3/9/2026
Regeneron Highlights Positive Chinese Phase III Data for Obesity Candi...
3/9/2026
Kelun Biotech and Harbour BioMed's SKB575 Receives IND Clearance in Ch...
3/9/2026
Hansoh's B7-H3 ADC Shows Promising Lung Cancer Activity in Cancer Cell...
3/9/2026
Hansoh Reports Positive Phase 3 Results for Weekly GLP-1/GIP Dual Agon...
3/9/2026
Merck KGaA Drops Hengrui-Licensed PARP1 Candidate After Early Clinical...
3/9/2026
Abbisko's Pimicotinib Phase 3 MANEUVER Results Published in The Lancet
3/6/2026
China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...
3/6/2026
Abbisko Doses First Patient in Trial of KRAS G12D Inhibitor ABSK141
3/6/2026
Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis
3/6/2026
Sciwind's Ecnoglutide Approved in China for Obesity
3/5/2026
CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug
3/4/2026
CSPC's Emicizumab Injection Receives Clinical Trial Approval in China
3/4/2026
Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...
3/4/2026
Eli Lilly Advances New Oral Diabetes Therapy in China
3/3/2026
LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...
3/3/2026
China Approves Five NMEs in February as Innovation Expands Globally
3/2/2026
China Approves Jaypirca for Expanded Blood Cancer Indications
3/2/2026
RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA
3/2/2026
MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China
3/2/2026
NMPA Approves Rovalicitinib for First-Line Myelofibrosis
3/2/2026
Innovent Registers Phase I Study for FIC Dual-Payload Bispecific ADC
3/2/2026
Sanofi Secures Two New China Approvals for Dupilumab
2/27/2026
CSPC Launches Phase III Program for SYH2053 PCSK9 siRNA in China
2/27/2026
Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
2/26/2026
BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
2/26/2026
Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...
2/26/2026
Jiuyuan Files for Approval of Wegovy Biosimilar in China
2/26/2026
Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
Page:
1
/
22
Total number of articles:
656
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit